Arrowhead's subsidiary Visirna has entered an agreement with Sanofi for plozasiran, a potential treatment for hypertriglyceridemia.

President Donald Trump's warnings about pharmaceutical tariffs have triggered a wave of manufacturing commitments from major ...

The Centre has made it mandatory to print QR codes on the packaging of the top 300 drug brands that sell medicines in India.

A 492-strong Cardiff-based pharmaceutical firm has posted a fall in turnover and profits in its latest year amid a decrease ...

Evidence-based medicine "Boy Wonder" Dr. Vinay Prasad was fired as CBER Director after less than three months on the job.

Europe’s cannabis pharmaceutical sector is shifting as scientific rigour, regulatory clarity and cautious capital define its next chapter.

Experts say what matters most is how the money is spent to build collaborative ecosystems and thriving innovation ...

Kolkata: Panic swept through the Bondel Gate area of south Kolkata on Saturday afternoon as a fire erupted at the Dey's ...

Madbouly affirmed the government’s interest in providing all necessary support for the growth and localisation of this vital industry ...

India Inc enters August with a heavy earnings calendar for Q1 FY26. Key companies such as Titan, SBI, Tata Motors, LIC, Biocon, Adani Ports, and Grasim will release results this week across auto, ...

After decades of limited progress—owing to the difficulty of treating the disease and resultant market risk—glioblastoma ...

Trump is using Section 232 and his Most Favoured Nation policy as twin levers in his push to lower drug prices.